Research that Identifies
Undiscovered Value in the MicroCap Market



C-Bond Systems, Inc.

C-Bond Systems Email Alerts: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg

Report Link: Initial Research Report (Dated 11/15/2019)

Symbol: CBNT
Analyst: John Nobile
Taglich Rating: Speculative Buy
Price Target: $0.25
Time Horizon: 12 Months
Rating Established: November 15, 2019
Price When Established: $0.08
Most Recent Report: November 15, 2019
Price When Issued: $0.08


What's New

C-Bond Systems Secures Partnership with MACOMA to Sell FN® NANO Photocatalytic Coatings to Combat Pathogen and Virus Spread such as COVID-19 and MRSA

On March 26, 2020, C-Bond Systems (OTC: CBNT) announced it has partnered with MACOMA Environmental Technologies, LLC to resell FN® NANO, a photocatalytic coating used in hospitals, acute care facilities, assisted living facilities, senior care facilities, athletic centers, schools, child-care facilities, arenas, airports, and other facilities to reduce the spread of airborne toxins and allergens, such as COVID-19 and MRSA.

Macoma is the exclusive U.S. distributor of environmentally safe, titanium dioxide (TiO2) photocatalytic nanotechnology coatings, which are becoming one of the most effective solutions to help combat COVID-19, MRSA and other deadly pathogens after application to ceilings, walls, building façades and roofs. Once sunlight or indoor UV light makes contact with the FN® NANO coated surface or FN® Dash-Boards, it activates the photocatalytic properties of the titanium dioxide and begins to eliminate airborne toxins and allergens.

Per the terms of the reseller agreement, C-Bond’s Safety Solutions division will offer Macoma’s FN® NANO photocatalytic coatings to hospitals, acute care facilities, assisted living facilities, senior care facilities, athletic centers, schools, child-care facilities, arenas, airports, and other facilities.


C-Bond Systems Reports 2019 Results

On March 25, 2020, C-Bond Systems, Inc. (OTC: CBNT) reported results for its fiscal year ended December 31, 2019.

For the year, the company reported that revenue increased 57.7% to $603,000. CBNT reported a net loss of $7.2 million or $(0.08) per share versus a loss of $9.9 million or $(0.14) per share in 2018.

Taglich Brothers’ estimates were for 2019 revenue of $691,000 and a net loss of $7.4 million or $(0.08) per share.


C-Bond Systems Expands Nanotechnology Product Offering for Transportation Solutions Group

On March 24, 2020, C-Bond Systems (OTC: CBNT) announced that it has expanded the nanotechnology product offering of its C-Bond Transportation Solutions Group.

C-Bond Transportation Solutions Group now offers a more robust product suite, powered by nanotechnology, for superior cleaning, anti-bacterial, and protection in automobile applications – with new branded products ranging from paint sealants to surface protectors.


C-Bond Systems Granted Key US Patent Notice of Allowance Supporting Underlying Chemistry of C-Bond Core Technology

On March 23, 2020, C-Bond Systems (OTC: CBNT) announced the US Patent and Trademark Office has issued a notice of allowance of US Patent application 14/128,620 to support the underlying nanotechnology of its C-Bond product portfolio.

The patent application describes glass strengthening and the invention of silane-based chemistry to strengthen glass and interact with the surface micro-structures to treat micro-fissures and micro-cracks on the glass surface. The patent application also references the strengthening of laminates on glass, or the strengthening of the bonding and adhesion of a laminate for window film, on glass or a laminated piece of glass.

The addition of this new patent notice of allowance moves C-Bond’s domestic and international portfolio to include 22 patents and applications spanning core nanotechnology processes.


C-Bond Establishes Two Divisions to Accelerate Expansion and Strategic Partnership Opportunities

On March 17, 2020, C-Bond Systems (OTC: CBNT) announced it has separated its business lines and established two new divisions: C-Bond Transportation Solutions and C-Bond Safety Solutions. The company is delineating the businesses in order to help accelerate expansion and better position them for strategic partnership opportunities.

C-Bond Transportation Solutions will include the C-Bond NanoShield™ product line and focus on sales efforts to fleet operators, new car dealers, service providers including glass repair and replacement, warranty and F&I companies, and windshield OEMs.

C-Bond Safety Solutions will include C-Bond BRS (ballistic-resistant system) and focus on sales efforts to continue installations at schools, government buildings, media outlets, and other high-security facilities.


C-Bond Achieves Record Revenue in 2019

On January 21, 2020, C-Bond Systems (OTC: CBNT) announced that it achieved record revenue in 2019, including more than $358,000 from sales of C-Bond BRS, its ballistic-resistant film system. Sales of C-Bond BRS grew more than 60% year-over-year.

To further the growth of C-Bond BRS in 2020 and beyond, management is focused on media outlets, among other organizations, which have become a significant customer for this security product.


C-Bond’s India Distributor Launched Online Sales of NanoShield

On January 6, 2020, C-Bond Systems (OTC: CBNT) announced that Quantron Business Tech Solutions Pvt Ltd., the company’s distributor in India, has launched online sales of C-Bond NanoShield with initial orders placed of approximately $50,000.


Company Description

C-Bond Systems, Inc., headquartered in Houston, Texas, is engaged in the implementation of proprietary nanotechnology applications and processes to enhance the strength, functionality and sustainability of brittle material systems. The company’s primary focus is on the multi-billion-dollar glass and window film industry with target markets in the US and internationally.


Company Reports

Initial Research Report (Dated November 15, 2019)


Disclaimer

Please view our current disclosure and disclaimer on our most recent research report.